Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce that it has submitted the Clinical Study Report to the U.S. Food ...
A healthcare provider will want to do some tests to see if there is an underlying cause for symptoms such as diarrhea, abdominal pain, and nausea or vomiting. A stool culture may be part of a number ...
Persephone Biosciences Inc., a commercial company restoring and reinvigorating the human gut microbiome through clinically validated synergistic synbiotics, today announced that the first subject has ...
reported a 0.47% incidence of NEC in infants who had only occult blood in the stools, a 63% incidence in those who had only gross blood, and a 90% incidence in those with occult blood progressing ...